Polyamines and colon cancer

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

Colorectal cancer is a major health problem in the western world and is associated with significant morbidity and mortality. Diet makes a significant contribution to the disease, with high fat, low fibre diets correlating positively with a high incidence of colorectal cancer. Intracellular polyamine concentrations and ornithine decarboxylase activity are both increased in colorectal cancer tissue and in premalignant polyps. Measurement of the polyamine content of serum and urine of individuals has been proposed as a diagnostic marker of malignancy but a number of false positives make this idea untenable. There may, however, still be a role for the measurement of urinary polyamine content as a means of monitoring the efficacy of therapy. Inhibition of polyamine metabolism by polyamine analogues or by non-steroidal anti-inflammatory drugs may be useful in the chemotherapy and/or chemoprevention of colorectal cancer. Preliminary results suggest that a low polyamine diet might be helpful as part of a health care plan for cancer patients. (C) 2001 Lippincott Williams & Wilkins.

Original languageEnglish
Pages (from-to)1033-1039
Number of pages6
JournalEuropean Journal of Gastroenterology & Hepatology
Volume13
Issue number9
DOIs
Publication statusPublished - 2001

Keywords

  • cancer chemotherapy
  • ornithine decarboxylase
  • putrescine
  • spermidine
  • spermine
  • NONSTEROIDAL ANTIINFLAMMATORY DRUGS
  • ORNITHINE DECARBOXYLASE ACTIVITY
  • COLORECTAL-CANCER
  • BREAST-CANCER
  • CELLS
  • GROWTH
  • CHEMOTHERAPY
  • INHIBITION
  • APOPTOSIS
  • POLYPOSIS

Cite this

Polyamines and colon cancer. / Wallace, Heather Mann; Caslake, Robert.

In: European Journal of Gastroenterology & Hepatology, Vol. 13, No. 9, 2001, p. 1033-1039.

Research output: Contribution to journalArticle

@article{8a42d177b2114ff69b10d6a9b1c45d01,
title = "Polyamines and colon cancer",
abstract = "Colorectal cancer is a major health problem in the western world and is associated with significant morbidity and mortality. Diet makes a significant contribution to the disease, with high fat, low fibre diets correlating positively with a high incidence of colorectal cancer. Intracellular polyamine concentrations and ornithine decarboxylase activity are both increased in colorectal cancer tissue and in premalignant polyps. Measurement of the polyamine content of serum and urine of individuals has been proposed as a diagnostic marker of malignancy but a number of false positives make this idea untenable. There may, however, still be a role for the measurement of urinary polyamine content as a means of monitoring the efficacy of therapy. Inhibition of polyamine metabolism by polyamine analogues or by non-steroidal anti-inflammatory drugs may be useful in the chemotherapy and/or chemoprevention of colorectal cancer. Preliminary results suggest that a low polyamine diet might be helpful as part of a health care plan for cancer patients. (C) 2001 Lippincott Williams & Wilkins.",
keywords = "cancer chemotherapy, ornithine decarboxylase, putrescine, spermidine, spermine, NONSTEROIDAL ANTIINFLAMMATORY DRUGS, ORNITHINE DECARBOXYLASE ACTIVITY, COLORECTAL-CANCER, BREAST-CANCER, CELLS, GROWTH, CHEMOTHERAPY, INHIBITION, APOPTOSIS, POLYPOSIS",
author = "Wallace, {Heather Mann} and Robert Caslake",
year = "2001",
doi = "10.1097/00042737-200109000-00006",
language = "English",
volume = "13",
pages = "1033--1039",
journal = "European Journal of Gastroenterology & Hepatology",
issn = "0954-691X",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Polyamines and colon cancer

AU - Wallace, Heather Mann

AU - Caslake, Robert

PY - 2001

Y1 - 2001

N2 - Colorectal cancer is a major health problem in the western world and is associated with significant morbidity and mortality. Diet makes a significant contribution to the disease, with high fat, low fibre diets correlating positively with a high incidence of colorectal cancer. Intracellular polyamine concentrations and ornithine decarboxylase activity are both increased in colorectal cancer tissue and in premalignant polyps. Measurement of the polyamine content of serum and urine of individuals has been proposed as a diagnostic marker of malignancy but a number of false positives make this idea untenable. There may, however, still be a role for the measurement of urinary polyamine content as a means of monitoring the efficacy of therapy. Inhibition of polyamine metabolism by polyamine analogues or by non-steroidal anti-inflammatory drugs may be useful in the chemotherapy and/or chemoprevention of colorectal cancer. Preliminary results suggest that a low polyamine diet might be helpful as part of a health care plan for cancer patients. (C) 2001 Lippincott Williams & Wilkins.

AB - Colorectal cancer is a major health problem in the western world and is associated with significant morbidity and mortality. Diet makes a significant contribution to the disease, with high fat, low fibre diets correlating positively with a high incidence of colorectal cancer. Intracellular polyamine concentrations and ornithine decarboxylase activity are both increased in colorectal cancer tissue and in premalignant polyps. Measurement of the polyamine content of serum and urine of individuals has been proposed as a diagnostic marker of malignancy but a number of false positives make this idea untenable. There may, however, still be a role for the measurement of urinary polyamine content as a means of monitoring the efficacy of therapy. Inhibition of polyamine metabolism by polyamine analogues or by non-steroidal anti-inflammatory drugs may be useful in the chemotherapy and/or chemoprevention of colorectal cancer. Preliminary results suggest that a low polyamine diet might be helpful as part of a health care plan for cancer patients. (C) 2001 Lippincott Williams & Wilkins.

KW - cancer chemotherapy

KW - ornithine decarboxylase

KW - putrescine

KW - spermidine

KW - spermine

KW - NONSTEROIDAL ANTIINFLAMMATORY DRUGS

KW - ORNITHINE DECARBOXYLASE ACTIVITY

KW - COLORECTAL-CANCER

KW - BREAST-CANCER

KW - CELLS

KW - GROWTH

KW - CHEMOTHERAPY

KW - INHIBITION

KW - APOPTOSIS

KW - POLYPOSIS

U2 - 10.1097/00042737-200109000-00006

DO - 10.1097/00042737-200109000-00006

M3 - Article

VL - 13

SP - 1033

EP - 1039

JO - European Journal of Gastroenterology & Hepatology

JF - European Journal of Gastroenterology & Hepatology

SN - 0954-691X

IS - 9

ER -